CARCINOEMBRYONIC ANTIGEN - ANVISA Registration 10310030237

Access comprehensive regulatory information for CARCINOEMBRYONIC ANTIGEN in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10310030237 and manufactured by WAMA PRODUTOS PARA LABORATORIO LTDA. The registration is held by WAMA PRODUTOS PARA LABORATORIO LTDA with validity until May 06, 2034.

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10310030237
Registration Details
ANVISA Registration Number: 10310030237
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Imuno-Rápido Quanti CEA
Risk Class III

Registration Details

10310030237

25351880464202330

66000787000108

Company Information

Brazil
PT: BRASIL

Dates and Status

May 06, 2024

06/05/2034

09/18/2025 19:00:01